|
流感抗A/Victoria/4897/2022样[H1N1]HA血清23/100
|
EA
|
23/100
|
4081
|
1-4/12周
|
|
流感抗原A/维多利亚/4897/2022[IVR-238][H1N1]22/320
|
EA
|
22/320
|
4081
|
1-4/12周
|
|
世界卫生组织絮凝试验用白喉抗毒素国际参考试剂[马]23/102
|
EA
|
23/102
|
4988
|
1-4/12周
|
|
甲基化人血清白蛋白[mHSA]23/106
|
EA
|
23/106
|
4502
|
1-4/12周
|
|
流感病毒传染性SAN-010[A/Darwin/09/2021][H3N2]23/114
|
EA
|
23/114
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型22F单克隆抗体[克隆17-122JB11IB11]22/306
|
EA
|
22/306
|
2883
|
1-4/12周
|
|
流感病毒传染性A/挪威/31694/2022[H1N1]22/312
|
EA
|
22/312
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型35B单克隆抗体[克隆3F9]22/308
|
EA
|
22/308
|
2883
|
1-4/12周
|
|
流感病毒传染性A/维多利亚/4897/2022[H1N1]22/316
|
EA
|
22/316
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型17F单克隆抗体[克隆17-120AE4IE3IG2]22/304
|
EA
|
22/304
|
2883
|
1-4/12周
|
|
流感病毒传染性IVR-238[A/Victoria/4897/2022[H1N1]22/318
|
EA
|
22/318
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型8单克隆抗体[克隆6G1]22/292
|
EA
|
22/292
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型11A单克隆抗体[克隆2E2]22/296
|
EA
|
22/296
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型12F单克隆抗体[克隆1C8]22/298
|
EA
|
22/298
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型15A-B单克隆抗体[克隆1B4]22/300
|
EA
|
22/300
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型10A单克隆抗体[克隆17-117DE8IIE9]22/294
|
EA
|
22/294
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型16F单克隆抗体[克隆20-121EC11IIF10VE2]22/302
|
EA
|
22/302
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型15B单克隆抗体[克隆2F4]22/278
|
EA
|
22/278
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型5单克隆抗体[克隆1366KG3IA11]22/288
|
EA
|
22/288
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型CPS单克隆抗体[克隆14-108BA5IE10]22/284
|
EA
|
22/284
|
2883
|
1-4/12周
|
